Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Neutra
Neutra has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?